Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel withdrawal 12 months after drug-eluting stent implantation
2007-000713-11Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clopidogrel in coronary arteriosclerosis, sponsored by Bristol Myers Squibb. Primary endpoint: Change in soluble CD40 ligand level after clopidogrel withdrawal. Started Jun 2007; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2007-000713-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000713-11.